Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Vericel Corporation, 3 years.
Vericel Corporation
Director
Invivyd Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Invivyd Inc. May 19, 202699.9%
-
Invivyd Inc. May 20, 202597.0%
-
Invivyd Inc. May 21, 202498.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Vericel Corporation | Option exercise | +7,000 | $13.05 | $91,350 |
| Aug 12, 2026 | Vericel Corporation | Open-market sale | −7,000 | $44.53 | $311,710 |
| May 13, 2026 | Vericel Corporation | Option exercise | +3,500 | $2.63 | $9,205 |
| May 13, 2026 | Vericel Corporation | Open-market sale | −3,500 | $32.83 | $114,905 |
| May 13, 2026 | Vericel Corporation | Option exercise | +3,500 | $13.05 | $45,675 |
| May 13, 2026 | Vericel Corporation | Open-market sale | −3,500 | $32.82 | $114,870 |
| Apr 29, 2026 | Vericel Corporation | Option exercise | +3,200 | — | — |
| Feb 11, 2026 | Vericel Corporation | Option exercise | +7,000 | $2.63 | $18,410 |
| Feb 11, 2026 | Vericel Corporation | Open-market sale | −7,000 | $34.66 | $242,620 |
| Nov 19, 2025 | Invivyd Inc. | Open-market purchase | +50,000 | $2.50 | $125,000 |
| Nov 10, 2025 | Vericel Corporation | Option exercise | +7,000 | $2.63 | $18,410 |
| Nov 10, 2025 | Vericel Corporation | Open-market sale | −7,000 | $38.59 | $270,130 |
| Aug 6, 2025 | Vericel Corporation | Option exercise | +7,000 | $2.76 | $19,320 |
| Aug 6, 2025 | Vericel Corporation | Open-market sale | −7,000 | $35.92 | $251,440 |
| May 7, 2025 | Vericel Corporation | Option exercise | +7,000 | $2.76 | $19,320 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.